# Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors

> **NCT04049903** · PHASE1 · COMPLETED · sponsor: **Molecular Partners AG** · enrollment: 38 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** MP0310

## Key facts

- **NCT ID:** NCT04049903
- **Lead sponsor:** Molecular Partners AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-02
- **Primary completion:** 2022-06-27
- **Final completion:** 2022-12-21
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04049903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04049903, "Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04049903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*